Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 24, 2025, Pulmonx (LUNG) has a market cap of $0.24 billion USD. According to our data, Pulmonx is ranked No.6941 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 24, 2025 | $0.24 B |
-11.05%
|
| Dec 31, 2024 | $0.27 B |
-46.75%
|
| Dec 29, 2023 | $0.50 B |
51.25%
|
| Dec 30, 2022 | $0.33 B |
-73.71%
|
| Dec 31, 2021 | $1.27 B |
-53.54%
|
| Dec 31, 2020 | $2.73 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Boston Scientific
BSX
|
$150.24 B |
-0.005 M
|
USA
|
 Medtronic
MDT
|
$115.65 B |
-0.002 M
|
Ireland
|
 Edwards Lifesciences
EW
|
$40.69 B |
-0.002 M
|
USA
|
 Abbott Laboratories
ABT
|
$216.86 B |
0.006 M
|
USA
|
 Teleflex
TFX
|
$8.36 B |
0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$353.49 B |
-0.001 M
|
USA
|
 Stryker Corporation
SYK
|
$150.32 B |
0.005 M
|
USA
|
 Zimmer Biomet
ZBH
|
$22.22 B |
0.000 M
|
USA
|
 Intuitive Surgical
ISRG
|
$208.03 B |
-0.008 M
|
USA
|
 ResMed
RMD
|
$36.77 B |
-0.002 M
|
USA
|
 Penumbra
PEN
|
$10.51 B |
0.000 M
|
USA
|
 Inogen
INGN
|
$0.26 B |
-0.000 M
|
USA
|
 Becton Dickinson
BDX
|
$70.60 B |
0.002 M
|
USA
|
 Masimo
MASI
|
$9.27 B |
-0.000 M
|
USA
|
| Market Cap | = | LUNG Stock Price | * | LUNG Shares Outstanding |
| = | $6.04 | * | 39.49 M | |
| = | $0.24 B |